Trial of Perioperative Tadalafil and Influenza Vaccination in Cancer Patients Undergoing Major Surgical Resection of a Primary Abdominal Malignancy

Trial Status: Closed
Start Date: November, 2017
Expected Enrolment: 28
Type of Trial: N/A
Protocol IDs: NCT02998736, 20160855-01H
Trial Design: Allocation: Randomized
Trial Phase: Phase 1
Medical Conditions: Abdominal Cancer
Drugs: Cialis
Lead Sponsor: Ottawa Hospital Research Institute
Sponsors/Study Groups: None specified
Type of Treatment: Biological: Influenza vaccine
Principal Investigator(s): Rebecca Auer, Doctor, The Ottawa Hospital
Date posted on December 6, 2016
Last updated: January 2, 2023
This trial was imported from

Interested in this trial?

Print this page and take it to your doctor to discuss your eligibilty and treatment options. Only your doctor can refer you to a clinical trial.


Canadian Cancer Society

These resources are provided in partnership with the Canadian Cancer Society